Vicarious Surgical Inc.RBOTNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-15.57%
↓ 292% below average
Average (22q)
8.12%
Historical baseline
Range
High:78.36%
Low:-39.09%
Volatility
1446.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -15.57% |
| Q2 2025 | -3.88% |
| Q1 2025 | 18.86% |
| Q4 2024 | -26.66% |
| Q3 2024 | -1.14% |
| Q2 2024 | 9.59% |
| Q1 2024 | 25.49% |
| Q4 2023 | -39.09% |
| Q3 2023 | 2.56% |
| Q2 2023 | -4.81% |
| Q1 2023 | 12.45% |
| Q4 2022 | -2.00% |
| Q3 2022 | 20.54% |
| Q2 2022 | 2.10% |
| Q1 2022 | 6.41% |
| Q4 2021 | 78.36% |
| Q3 2021 | 29.47% |
| Q2 2021 | 11.12% |
| Q1 2021 | 21.65% |
| Q4 2020 | 18.41% |
| Q3 2020 | 8.40% |
| Q2 2020 | 14.53% |
| Q1 2020 | 0.00% |